Labcorp Holdings Inc.
Income Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $10.31B | $9.55B | $8.68B | $6.01B | $5.81B | $5.67B | $5.54B | $5.00B |
| Cost of Revenue | $7.22B | $6.70B | $5.78B | $3.81B | $3.59B | $3.42B | $3.27B | $2.91B |
| Gross Profit | $3.09B | $2.85B | $2.90B | $2.20B | $2.22B | $2.25B | $2.27B | $2.10B |
| Gross Margin | 30.0% | 29.9% | 33.4% | 36.6% | 38.3% | 39.7% | 41.0% | 41.9% |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $1.50B | $1.35B | $1.63B | $1.20B | $1.13B | $1.11B | $1.16B | $1.03B |
| Operating Income | $1.31B | $1.27B | $996.8M | $910.4M | $990.9M | $1.02B | $948.4M | $978.8M |
| Operating Margin | 12.7% | 13.3% | 11.5% | 15.1% | 17.1% | 18.0% | 17.1% | 19.6% |
| Interest Expense | $235.1M | $219.1M | $274.9M | $109.5M | $96.5M | $94.5M | $87.5M | $70.0M |
| Pretax Income | — | — | — | — | — | — | — | — |
| Income Tax Expense | $-155.4M | $360.7M | $287.3M | $314.1M | $340.2M | $359.4M | $333.0M | $344.0M |
| Net Income | $1.23B | $711.8M | $437.6M | $511.2M | $573.8M | $583.1M | $519.7M | $558.2M |
| Net Margin | 11.9% | 7.5% | 5.0% | 8.5% | 9.9% | 10.3% | 9.4% | 11.2% |
| EPS (Basic) | $11.99 | $6.94 | $4.43 | $6.03 | $6.36 | $6.09 | $5.20 | $5.42 |
| EPS (Diluted) | $11.81 | $6.82 | $4.35 | $5.91 | $6.25 | $5.99 | $5.11 | $5.29 |
| Shares Outstanding (Basic) | 102.4M | 102.5M | 98.8M | 84.8M | 90.2M | 95.7M | 100.0M | 103.0M |
| Shares Outstanding (Diluted) | 103.9M | 104.3M | 100.6M | 86.4M | 91.8M | 97.4M | 101.8M | 105.4M |
| Dividends Per Share | — | — | — | — | — | — | — | — |